/ books / iu / mbiu

Cell Cycle Checkpoints and Cancer


Email this Print this

Mikhail V. Blagosklonny
National Cancer Institute

List price: $149.00
add book to cart.

pdf price: $99.00
add pdf to cart.


ISBN: 978-1-58706-067-0
Pub date: 2002-02-01
221 pages
60 figures
4 tables


About this book

This book addresses mechanisms of normal and cancer cell cycling, checkpoint control, the link of mitogenic signaling and cell cycle machinery. Considerable attention is devoted to the analysis of checkpoint mechanisms from yeast to man allowing us to understand the logic of the cell cycle. Applications to current and future anticancer therapies is discussed throughout the book and especially in the last chapters.

Table of contents

Introductory Chapter: Advances in Research and Challenges in Therapy
Mikhail V. Blagosklonny

Autocrine Transformation: Cytokine Model
James McCubrey, Xiao-yang Wang, Paul A. Algate, William L. Blalock, Linda S. Steelman

Signal Transduction Pathways: Cytokine Model
James McCubrey, William L. Blalock, Fumin Chang, Linda S. Steelman, Steven C. Pohnert, Patrick M. Navolanic, John G. Shelton, Paul E. Hoyle, Phillip W. Moye,
Stephanie M. Oberhaus, Martyn K White, John T. Lee and Richard A. Franklin

The Restriction Point of the Cell Cycle
Mikhail V. Blagosklonny and Arthur B. Pardee

DNA Damage, Cell Cycle Control, and Cancer
Jens Oliver Funk, Temesgen Samuel and H. Oliver Weber

DNA Damage-Independent Checkpoints from Yeast to Man
Duncan J. Clarke, Adrian P.L. Smith and Juan F. Giménez-Abián

The Regulation of p53 Growth Suppression
Ronit Vogt Sionov, Igal Louria Hayon and Ygal Haupt

Functional Interactions Between BRCA1 and the Cell Cycle
Timothy K. MacLachlan and Wafik El-Deiry

The Role of FHIT in Carcinogenesis
Yuri Pekarsky, Kay Huebner and Carlo M. Croce

Hypoxia and Cell Cycle
Rachel A. Freiberg, Susannah L. Green and Amato J. Giaccia

G2 Checkpoint and Anticancer Therapy
Zoe A. Stewart and Jennifer A. Pietenpol

p53, Apoptosis, and Cancer Therapy
Rosandra Kaplan and David E. Fisher

Non-Apoptotic Responses to Anticancer Agents: Mitotic Catastrophe, Senescence, and the Role of p53 and p21
Igor B. Roninson , Bey-Dih Chang and Eugenia V. Broude

Small Molecule Inhibitors of Cyclin-Dependent Kinases: Preclinical
and Clinical Development
Geoffrey I. Shapiro

Cell Cycle Molecular Targets and Drug Discovery
John K. Buolamwini